Chrystal Capital Partners LLP acts as exclusive financial advisor to EMMAC Life Sciences Group on its £15m raise via successful issue of convertible notes
Chrystal Capital Partners LLP ("Chrystal"), a Mayfair-based entrepreneurial corporate finance and investment house, is pleased to announce that is has acted as exclusive financial advisor to EMMAC Life Sciences Group ("EMMAC"), Europe's largest independent cannabis company, on its £15m raise via an issue of Convertible Loan Notes (the "CLN Issue"). The CLN Issue saw strong support from existing shareholders, with Measure 8 Venture Partners LP, EMMAC's largest existing cash investor, leading the round with a significant investment.
Chrystal's cannabis group, Chrystal Capital Cannabis Advisory ("CCCA"), is the only dedicated Cannabis Corporate Finance advisory team in Europe. This raise marks the 13th cannabis deal that CCCA's team has closed in the last 4 years. CCCA's team have now raised and advised on over $400m of transactions in the cannabis sector, across North America, Latin America and Europe.
“We are delighted to have advised EMMAC, Europe’s largest independent cannabis company, on this successful, oversubscribed £15m raise. Our cannabis sector expertise, married with our deep relationships with cannabis investors, continue to deliver much needed growth capital to this exciting, fast growing industry. CCCA is uniquely positioned to back leaders like EMMAC as the secular wave of cannabis deregulation and legalisation continues to unfold at pace across the world.”
About EMMAC Life Sciences Group
EMMAC Life Sciences Group is Europe's largest independent cannabis company, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. With a unique supply and distribution network throughout Europe, EMMAC's vision is to bring the life-enhancing potential of cannabis to the people who need it. For more information about EMMAC, please visit https://www.emmac.com/.
For further information please contact:
Kingsley Wilson
Investment Partner
kingsley.wilson@chrystalcapital.com
https://www.chrystalcapital.com